Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
TABLET
**Dosage** In the treatment of schizophrenia initial doses of 200 to 400mg twice daily by mouth may be given, increased if necessary up to a maximum of 1,2g twice daily. Usual maintenance doses are 400 to 800mg daily by mouth. The usual dose of Devodil in the treatment of nausea, vomiting is 150 to 300mg daily in divided doses.
ORAL
Medical Information
**Indications** Devodil is indicated for the treatment of psychosomatic components of organic diseases, e.g., nausea, vomiting; and acute or chronic psychiatric disorders.
**Contra-indications** Devodil is contra-indicated in patients with pheochromocytoma and during pregnancy.
N05AL01
sulpiride
Manufacturer Information
GOLDPLUS UNIVERSAL PTE LTD
REMEDICA LTD
Active Ingredients
Documents
Package Inserts
Devodil tablets PI.pdf
Approved: March 14, 2023